Who Will Be The First To Get A Psychedelic Drug Through The FDA To Commercialization?Psyched Wellness Is Laser Focused On Bringing Truly Differentiated Mushroom Products To MarketAtai Life Sciences: The Next Unicorn Of The Psychedelics SectorATAI Life Sciences Announces Closing of $125 Million Series C Financing RoundRritual Mushrooms Is Pioneering The Future Of Functional FoodsMindMed’s Drug Delivery Business Is One That Psychedelic Sector Investors Need To Be WatchingPure Extracts Technologies Corporate UpdateNova Mentis Life Science Announces Receipt of Pilz Shareholder ApprovalField Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle ProgramPsyched Wellness Ltd. Announces Insider Buying and Option Grant to Professor NuttMindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial froTryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific OfficerHavn Life Announces Launch of a Range of Natural Health ProductsCybin Corp. Will Make Its Debut Today On The NEO Under The Symbol “CYBN”Tryp Therapeutics Has “The Right Stuff” To Bring Psychedelic Therapies Through To CommercializationMindset Pharma Closes Ontario Brain Institute Funding and Announces Private Placement OfferingNuminus Wellness Is Executing Flawlessly On Their B2B Strategy via Numinus BiosciencesEntheon Biomedical Corp. (formerly MPV Exploration Inc.) Announces Completion of Amalgamation and Final Approval from thCybin Completes Reverse Take-Over TransactionThe Psychedelic Sector Is Getting A Major Momentum Boost Post U.S. Election
Back

CSE Bulletin: New Listing – Psyched Wellness Ltd. (PSYC)

Oct 22, 2020 • 7:23 AM EDT
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief and relaxation, assist with sleeping and to support mood.

Les actions ordinaires de Psyched Wellness Ltd. ont été approuvées pour inscription au CSE.

Les documents d’inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation.

Psyched Wellness Ltd. est une société canadienne de suppléments de santé dédiée à la distribution de produits dérivés de champignons et de produits de consommation associés. L’objectif de la société est de créer des produits dérivés de champignons de première qualité qui ont le potentiel de devenir une marque nord-américaine de premier plan dans la catégorie émergente des aliments fonctionnels. La société est en train de développer une gamme d’extraits, de thés et de capsules à base d’eau Amanita muscaria, conçus pour aider à atteindre trois objectifs de santé: favoriser le soulagement du stress et la relaxation, aider à dormir et maintenir l’humeur.

Issuer/Émetteur: Psyched Wellness Ltd.
Security Type/Titre: Common Shares/Actions ordinaires
Symbol(s)/Symbole(s): PSYC
Number of securities issued and outstanding/ Titres émis et en circulation: 104 642 930
Number of Securities reserved for issuance/ Titres réservés pour émission: 9 681 200
CSE Sector/Catégorie: Life Sciences/Sciences biologiques
CUSIP: 74447P 10 0
ISIN: CA 74447P 10 0 9
Boardlot/Quotité: 500
Trading Currency/Monnaie de négociation: CDN$/$CDN
Trading Date/Date de negociation: le 22 octobre/October 2020
Other Exchanges/Autres marches: N/A
Fiscal Year end /Clôture de l’exercice financier: le 30 novembre/November
Transfer Agent/Agent des transferts: TSX Trust Company

 

The Exchange is accepting Market Maker applications for PSYC. Please email: Trading@theCSE.com

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse: Listings@thecse.com

Source: Newsfile Corp. (October 21, 2020 – 5:48 PM EDT)

News by QuoteMedia
www.quotemedia.com

Share Share - Facebook Share - Twitter

Tags

Authored By

Michael Berger

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link